ATS Medical, Inc. Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	60
ISBN Number	not applicable
Product Code	GMD04729

Price

£400.00
approximately: $747 | €507

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a ATS Medical, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Industry Outlook - Cardiovascular Devices
3 ATS Medical, Inc. Pipeline Products
- 3.1 ATS Medical, Inc. Product Pipeline Analysis
  - 3.1.1 ATS Medical, Inc. Pipeline Products By Equipment Type
  - 3.1.2 ATS Medical, Inc. Pipeline Products By Development Stage
  - 3.1.3 ATS Medical, Inc. Pipeline Products By Therapy Area
  - 3.1.4 ATS Medical, Inc. Pipeline Products By Clinical Trials
  - 3.1.5 ATS Medical, Inc. Pipeline Products By News Summary
- 3.2 ATS Simulus Semi-Rigid Annuloplasty Ring
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Product Milestone
- 3.3 ATS 3F Aortic Bioprosthesis
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Product Pricing
  - 3.3.4 Product Milestone
- 3.4 ATS Open Pivot AP360 Mechanical Heart Valve
  - 3.4.1 Product Description
  - 3.4.2 Product Status
  - 3.4.3 Product Pricing
  - 3.4.4 Product Milestone
- 3.5 3f Aortic (Model 1000)
  - 3.5.1 Product Description
  - 3.5.2 Product Status
  - 3.5.3 Clinical Trials
  - 3.5.4 Product Milestone
- 3.6 3f Mitral Apparatus
  - 3.6.1 Product Description
  - 3.6.2 Product Status
- 3.7 3F Endurance Valve System
  - 3.7.1 Product Description
  - 3.7.2 Product Status
- 3.8 ATS Entrata Aortic Valve System
  - 3.8.1 Product Description
  - 3.8.2 Product Status
- 3.9 ATS 3F Enable Aortic Heart Valve
  - 3.9.1 Product Description
  - 3.9.2 Product Status
  - 3.9.3 Product Patent Details
- 3.10 ATS Simulus Adjustable repair rings
  - 3.10.1 Product Description
  - 3.10.2 Product Status
- 3.11 ATS CryoMaze Probe - New Version
  - 3.11.1 Product Description
  - 3.11.2 Product Status
  - 3.11.3 Clinical Trials
  - 3.11.4 Product Milestone
- 3.12 ATS FrostByte Clamp - New Version
  - 3.12.1 Product Description
  - 3.12.2 Product Status
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Financial Deals Landscape
- 10.1 Acquisition
  - 10.1.1 ATS Medical Acquires 3F Therapeutics
- 10.2 IPO
  - 10.2.1 ATS Medical Completes Private Placement Of $16.25 Million
- 10.3 Partnership
  - 10.3.1 Regeneration Technologies Signs An Agreement With ATS Medical
  - 10.3.2 CryoCath Technologies Signs An Agreement With ATS Medical
11 Recent Developments
- 11.1 Strategy and Business Planning
  - 11.1.1 Jun 07, 2007: Genzyme To Build New Biomanufacturing Plant
  - 11.1.2 Oct 18, 2006: MMV, Genzyme And Broad Institute Collaborate To Discover New Drugs For Malaria
- 11.2 Product Announcements
  - 11.2.1 Apr 14, 2008 Genzyme Genetics Announces Launch Of Carrier Testing And Prenatal Diagnosis For Spinal Muscular Atrophy
  - 11.2.2 Dec 19, 2007 Genzyme Receives European CE Mark For Single-Treatment Synvisc-One
  - 11.2.3 Nov 13, 2007 Genzyme Corporation Receives FDA Response Letter On Synvisc-One Approval In US To Be Delayed
  - 11.2.4 Nov 13, 2007 Genzyme Receives FDA Response Letter On Synvisc-One
  - 11.2.5 Jul 05, 2007 Genzyme Announces Results Of Clinical Trial For Hylastan
  - 11.2.6 Dec 04, 2006: Genzyme Launches New Genetic Test
- 11.3 Financial Announcements
  - 11.3.1 Apr 23, 2008: Genzyme Declares Q1 2008 Results
  - 11.3.2 Feb 13, 2008: Genzyme Declares Q4 2007 Results
  - 11.3.3 Oct 24, 2007: Genzyme Declares Q3 2007 Results
  - 11.3.4 Jul 25, 2007: Genzyme Declares Q2 2007 Results
  - 11.3.5 May 29, 2007: Genzyme Approves $1.5 Billion Share Repurchase Program
  - 11.3.6 Apr 25, 2007: Genzyme Raises 2007 Non-GAAP Earnings Forecast
  - 11.3.7 Apr 25, 2007: Genzyme Reports Q1 Results
  - 11.3.8 Feb 14, 2007: Genzyme Provides Strong Outlook For 2007
  - 11.3.9 Feb 14, 2007: Genzyme Declares Q4 2006 Results
  - 11.3.10 Jan 09, 2007: Genzyme Reports Q4 2006 Revenue Growth
  - 11.3.11 Oct 12, 2006: Genzyme Declares Q3 2006 Results
  - 11.3.12 Jul 12, 2006: Genzyme Declares Q2 2006 Results
- 11.4 Other Significant Developments
  - 11.4.1 Aug 09, 2007: Genzyme Settles Lawsuit Brought By Shareholders
  - 11.4.2 Oct 30, 2006: Genzyme To Challenge Medicare Code And Reimbursement Decision
  - 11.4.3 Aug 31, 2006: Genzyme Commends New Book For Portraying Challenges
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
List of Tables
- Table 1: ATS Medical, Inc.,Key Facts
- Table 2: ATS Medical, Inc. Pipeline Products by Equipment Type
- Table 3: ATS Medical, Inc. Pipeline Products By Development Stage
- Table 4: ATS Medical, Inc. Pipeline Products By Therapy Area
- Table 5: ATS Medical, Inc. Pipeline Products By Clinical Trials
- Table 6: ATS Medical, Inc. Pipeline Products By News Summaries
- Table 7: ATS Medical, Inc., Key Employees,
- Table 8: ATS Medical, Inc., Other Locations
List of Figures
- Figure 1: ATS Medical, Inc. Pipeline Products By News Summary
- Figure 2: Global Markets Direct Methodology